Heterogeneity of the tumor immune microenvironment and its clinical relevance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterogeneity of the tumor immune microenvironment and its clinical relevance
Authors
Keywords
-
Journal
Experimental Hematology & Oncology
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-23
DOI
10.1186/s40164-022-00277-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- Immune Checkpoint Inhibitors and Cellular Treatment for Lymphoma Immunotherapy
- (2021) Fang Li et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CRISPR/Cas9-engineered universal CD19/CD22 dual-targeted CAR-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia
- (2021) Yongxian Hu et al. CLINICAL CANCER RESEARCH
- Germline genetic contribution to the immune landscape of cancer
- (2021) Rosalyn W. Sayaman et al. IMMUNITY
- Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
- (2021) Wenfeng Fang et al. Molecular Cancer
- PD-L1 as a biomarker of response to immune-checkpoint inhibitors
- (2021) Deborah Blythe Doroshow et al. Nature Reviews Clinical Oncology
- Non-genetic evolution drives lung adenocarcinoma spatial heterogeneity and progression
- (2021) Daniele Tavernari et al. Cancer Discovery
- An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
- (2021) Hubert Lam et al. Cancer Discovery
- Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms
- (2021) Hiroshi Kondo et al. Cell Reports
- Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma
- (2021) Tao Jiang et al. npj Precision Oncology
- Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma
- (2021) Meijing Liu et al. CANCER SCIENCE
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
- (2021) Stefan C. Dentro et al. CELL
- Different spatial distribution of inflammatory cells in the tumor microenvironment of ABC and GBC subgroups of diffuse large B cell lymphoma
- (2021) Diego Guidolin et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
- (2021) Ying Gong et al. Journal of Hematology & Oncology
- Cell-programmed nutrient partitioning in the tumour microenvironment
- (2021) Bradley I. Reinfeld et al. NATURE
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
- (2021) Ayse Bassez et al. NATURE MEDICINE
- Navigating CAR-T cells through the solid-tumour microenvironment
- (2021) Andrew J. Hou et al. NATURE REVIEWS DRUG DISCOVERY
- Tracking Cancer Evolution through the Disease Course
- (2021) Chris Bailey et al. Cancer Discovery
- Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
- (2021) Qijie Zhao et al. Frontiers in Immunology
- Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer
- (2021) Wenbin Zhou et al. Journal for ImmunoTherapy of Cancer
- Perspectives on Epigenetics and Cancer Immunotherapy: A Preface to Special Issue
- (2021) Damiana Alvarez-Errico Cancers
- Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy
- (2021) Penny Q. Fang et al. Frontiers in Oncology
- Programmed cell death protein-1 inhibitor combined with chimeric antigen receptor T cells in the treatment of relapsed refractory non-Hodgkin lymphoma: A case report
- (2021) Zhi-Yun Niu et al. World Journal of Clinical Cases
- Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel–treated patients in the TRANSCEND NHL 001 trial
- (2021) Jeremy S. Abramson et al. Blood Advances
- Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy
- (2021) Ping Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
- (2021) Vicki Plaks et al. BLOOD
- Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
- (2021) Tong Fu et al. Journal of Hematology & Oncology
- Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity
- (2021) Andy Karabajakian et al. ORAL ONCOLOGY
- Vascular Microenvironment, Tumor Immunity and Immunotherapy
- (2021) Zachary Lamplugh et al. Frontiers in Immunology
- Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences
- (2020) Sushant Kumar et al. CELL
- Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment
- (2020) Yelei Guo et al. Cellular & Molecular Immunology
- Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancer
- (2020) Yosuke Hirotsu et al. JOURNAL OF GASTROENTEROLOGY
- Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
- (2020) Katharina von Loga et al. Nature Communications
- Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases
- (2020) Zheng Hu et al. NATURE GENETICS
- Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
- (2020) Khalid AbdulJabbar et al. NATURE MEDICINE
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- CD19-directed CAR T-cell therapy in B-cell NHL
- (2020) Marie José Kersten et al. CURRENT OPINION IN ONCOLOGY
- When, why and how tumour clonal diversity predicts survival
- (2020) Robert Noble et al. Evolutionary Applications
- Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
- (2020) Takahiro Yamazaki et al. NATURE IMMUNOLOGY
- Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
- (2020) Wei Sang et al. Cancer Medicine
- Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
- (2020) Ashley Maynard et al. CELL
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- Spatial and temporal heterogeneity of PD-L1 expression and tumor mutational burden in gastroesophageal adenocarcinoma at baseline diagnosis and after chemotherapy
- (2020) Katherine I Zhou et al. CLINICAL CANCER RESEARCH
- Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
- (2020) Nirav N. Shah et al. NATURE MEDICINE
- Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy
- (2020) Soniya Bastola et al. Nature Communications
- Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors
- (2020) Vladimir Roudko et al. CELL
- Reconnaissance of Tumor Immune Microenvironment Spatial Heterogeneity in Metastatic Renal Cell Carcinoma and Correlation with Immunotherapy Response
- (2020) Ali Hajiran et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
- (2019) Vitor H. Teixeira et al. NATURE MEDICINE
- Genomic correlates of response to immune checkpoint blockade
- (2019) Tanya E. Keenan et al. NATURE MEDICINE
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma
- (2019) Zhihua Gong et al. Journal of Thoracic Oncology
- Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
- (2019) Jacob H. Rasmussen et al. BRITISH JOURNAL OF CANCER
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Metabolic regulation of cell growth and proliferation
- (2019) Jiajun Zhu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response
- (2019) Rajarsi Mandal et al. SCIENCE
- Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
- (2019) Ting Yan et al. Nature Communications
- Immune evasion before tumour invasion in early lung squamous carcinogenesis
- (2019) Céline Mascaux et al. NATURE
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- Crizotinib-induced immunogenic cell death in non-small cell lung cancer
- (2019) Peng Liu et al. Nature Communications
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
- (2019) Michal Harel et al. CELL
- UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
- (2019) Yochai Wolf et al. CELL
- Chimeric antigen receptor T cells targeting CD79b show efficacy in lymphoma with or without co-targeting CD19
- (2019) Maria Ormhøj et al. CLINICAL CANCER RESEARCH
- Pembrolizumab for the treatment of diffuse large B-cell lymphoma
- (2019) Semira Sheikh et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma
- (2019) Chao Zhang et al. Journal of Thoracic Oncology
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
- (2019) Kroopa Joshi et al. NATURE MEDICINE
- Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry
- (2019) Yu-Kuan Huang et al. Nature Communications
- Non-Genetic Intra-Tumor Heterogeneity Is a Major Predictor of Phenotypic Heterogeneity and Ongoing Evolutionary Dynamics in Lung Tumors
- (2019) Anchal Sharma et al. Cell Reports
- Metabolic heterogeneity confers differences in melanoma metastatic potential
- (2019) Alpaslan Tasdogan et al. NATURE
- Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
- (2019) Maria Esperanza Rodriguez-Ruiz et al. NATURE IMMUNOLOGY
- Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
- (2019) Tomohiro Aoki et al. Cancer Discovery
- Programmed death ligand 1 expression and CD8 + tumor-infiltrating lymphocyte density differences between paired primary and brain metastatic lesions in non-small cell lung cancer
- (2018) Jie Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
- (2018) Ming Li et al. BMC CANCER
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
- (2018) Allen W. Zhang et al. CELL
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma
- (2018) Christopher J. Ricketts et al. CELL
- Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
- (2018) Shamzah Araf et al. LEUKEMIA
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Phenotype molding of stromal cells in the lung tumor microenvironment
- (2018) Diether Lambrechts et al. NATURE MEDICINE
- Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
- (2018) Darren K. Patten et al. NATURE MEDICINE
- Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
- (2018) Shashi Gujar et al. TRENDS IN IMMUNOLOGY
- Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- (2018) Catherine S. Grasso et al. Cancer Discovery
- Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors
- (2018) Inga H. Rye et al. Molecular Oncology
- Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape
- (2018) Carl DeSelm et al. MOLECULAR THERAPY
- Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
- (2018) Diana Miao et al. NATURE GENETICS
- Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability
- (2018) Franck Raynaud et al. PLoS Genetics
- Cancer Neoantigens
- (2018) Ton N. Schumacher et al. Annual Review of Immunology
- Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
- (2018) Hanjie Li et al. CELL
- Single Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
- (2018) Vincent Bernard et al. CLINICAL CANCER RESEARCH
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
- (2018) Lei Zhang et al. NATURE
- Linking cellular stress responses to systemic homeostasis
- (2018) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
- (2018) Qingzhu Jia et al. Nature Communications
- Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
- (2018) Michael Bartoschek et al. Nature Communications
- Rejection of immunogenic tumor clones is limited by clonal fraction
- (2018) Ron S Gejman et al. eLife
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
- (2017) Nathan C Sheffield et al. NATURE MEDICINE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication
- (2017) Steven Lemery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Epigenetic plasticity and the hallmarks of cancer
- (2017) William A. Flavahan et al. SCIENCE
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Computational pathology: Exploring the spatial dimension of tumor ecology
- (2016) Sidra Nawaz et al. CANCER LETTERS
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
- (2016) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Identification of neutral tumor evolution across cancer types
- (2016) Marc J Williams et al. NATURE GENETICS
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
- (2016) Sheng Li et al. NATURE MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metastasis as an evolutionary process
- (2016) S. Turajlic et al. SCIENCE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Epigenetic control of the tumor microenvironment
- (2016) David L Marks et al. Epigenomics
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
- (2015) S. Arena et al. CLINICAL CANCER RESEARCH
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- (2015) Lucy R Yates et al. NATURE MEDICINE
- Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
- (2015) E. Vacchelli et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Evolutionary Determinants of Cancer
- (2015) M. Greaves Cancer Discovery
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
- (2015) Roland F. Schwarz et al. PLOS MEDICINE
- Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
- (2014) Andriy Marusyk et al. NATURE
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
- (2014) S. Misale et al. Cancer Discovery
- Oncolytic Viruses and Their Application to Cancer Immunotherapy
- (2014) E. A. Chiocca et al. Cancer Immunology Research
- Autophagy-dependent ATP release from dying cells via lysosomal exocytosis
- (2013) Yidan Wang et al. Autophagy
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Coevolution in the tumor microenvironment
- (2008) Robert A Weinberg NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search